Immune markers are associated with cognitive performance in a multiethnic cohort: The Northern Manhattan Study
- PMID: 34320382
- PMCID: PMC8453105
- DOI: 10.1016/j.bbi.2021.07.011
Immune markers are associated with cognitive performance in a multiethnic cohort: The Northern Manhattan Study
Abstract
Objective: To determine whether immune protein panels add significant information to correlates of cognition.
Background: Immune mechanisms in vascular cognitive aging are incompletely characterized.
Design/methods: A subsample of the prospective Northern Manhattan Study underwent detailed neuropsychological testing. Cognitive scores were converted into Z-scores and categorized into four domains (memory, language, processing speed, and executive function) based on factor analysis. Blood samples were analyzed using a 60-plex immunoassay. We used least absolute shrinkage and selection operator (LASSO) procedures to select markers and their interactions independently associated with cognitive scores. Linear regression models assessed cross-sectional associations of known correlates of cognition with cognitive scores, and assessed model fit before and after addition of LASSO-selected immune markers.
Results: Among 1179 participants (mean age 70 ± 8.9 years, 60% women, 68% Hispanic), inclusion of LASSO-selected immune markers improved model fit above age, education, and other risk factors (p for likelihood ratio test < 0.005 for all domains). C-C Motif Chemokine Ligand 11 (CCL 11, eotaxin), C-X-C Motif Chemokine Ligand 9 (CXCL9), hepatocyte growth factor (HGF), and serpin E1 (plasminogen activator inhibitor-1) were associated with each of the domains and with overall cognitive function. Immune marker effects were comparable to conventional risk factors: for executive function, each standard deviation (SD) increase in CCL11 was associated with an effect equivalent to aging three years; for memory, HGF had twice the effect of aging.
Conclusions: Immune markers associate with cognitive function in a multi-ethnic cohort. Further work is needed to validate these findings and determine optimal treatment targets.
Keywords: Cognition; Cohort studies; Epidemiology; Immune function; Innate immunity; Vascular dementia.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest:
Dr. Elkind receives royalties from UpToDate for chapters on stroke and COVID-19.
Ms. Moon declares no conflicts of interest.
Dr. Cheung declares no conflicts of interest.
Dr. Sacco declares no conflict of interest.
Dr. Hornig declares no conflict of interest.
Dr. Rundek declares no conflict of interest.
Similar articles
-
Immune Markers Are Associated With Asymptomatic Intracranial Large Artery Stenosis and Future Vascular Events in NOMAS.Stroke. 2023 Dec;54(12):3030-3037. doi: 10.1161/STROKEAHA.123.044237. Epub 2023 Nov 1. Stroke. 2023. PMID: 37909207 Free PMC article.
-
Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.J Alzheimers Dis. 2020;73(3):1221-1231. doi: 10.3233/JAD-190925. J Alzheimers Dis. 2020. PMID: 31884476 Free PMC article.
-
Infectious Burden and Cognitive Decline in the Northern Manhattan Study.J Am Geriatr Soc. 2015 Aug;63(8):1540-5. doi: 10.1111/jgs.13557. J Am Geriatr Soc. 2015. PMID: 26289683 Free PMC article.
-
Sex-specific associations between cerebrospinal fluid inflammatory marker levels and cognitive function in antiretroviral treated people living with HIV in rural Uganda.Brain Behav Immun. 2021 Mar;93:111-118. doi: 10.1016/j.bbi.2020.12.021. Epub 2020 Dec 24. Brain Behav Immun. 2021. PMID: 33359628 Free PMC article.
-
Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study.J Int Neuropsychol Soc. 2014 Nov;20(10):951-60. doi: 10.1017/S1355617714000861. Epub 2014 Nov 10. J Int Neuropsychol Soc. 2014. PMID: 25382144 Free PMC article.
Cited by
-
Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia.Front Aging Neurosci. 2023 May 25;15:1180913. doi: 10.3389/fnagi.2023.1180913. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37304071 Free PMC article.
-
Polygenic proxies of age-related plasma protein levels reveal TIMP2 role in cognitive performance.Res Sq [Preprint]. 2024 Oct 18:rs.3.rs-5267673. doi: 10.21203/rs.3.rs-5267673/v1. Res Sq. 2024. PMID: 39483923 Free PMC article. Preprint.
-
Chemokines play a role in nerve damage and neuroprotection in vascular dementia.IBRO Neurosci Rep. 2024 Aug 5;17:154-160. doi: 10.1016/j.ibneur.2024.08.002. eCollection 2024 Dec. IBRO Neurosci Rep. 2024. PMID: 39206161 Free PMC article. Review.
-
Inflammatory biomarkers profiles and cognition among older adults.Sci Rep. 2025 Jan 17;15(1):2265. doi: 10.1038/s41598-025-86309-z. Sci Rep. 2025. PMID: 39824904 Free PMC article.
-
Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort.Aging Cell. 2023 Oct;22(10):e13955. doi: 10.1111/acel.13955. Epub 2023 Aug 16. Aging Cell. 2023. PMID: 37584418 Free PMC article.
References
-
- Schwartz M, Peralta Ramos JM, Ben-Yehuda H. A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer's Disease. Journal of immunology (Baltimore, Md : 1950) 2020;204:243–50. - PubMed
-
- Esenwa CC, Elkind MS. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol 2016;12:594–604. - PubMed
-
- Itzhaki RF, Golde TE, Heneka MT, Readhead B. Do infections have a role in the pathogenesis of Alzheimer disease? Nat Rev Neurol 2020;16:193–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials